Histogenics Corporation to Present at 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017 – Nasdaq
|
Histogenics Corporation to Present at 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017
Nasdaq The event includes clinical and commercial experts who are on-hand to address specific questions regarding the outlook for these products, as well as offer insight into how cell and gene therapies could impact the standard of care in key therapeutic … ViaCyte to Present at ARM's 5th Annual Cell & Gene Therapy … Homology Medicines Announces Four Presentations on its Gene … Sangamo Therapeutics Announces Participation In The ARM 5th Annual Cell & Gene Therapy Investor Day |
